Peter G. Linde
Corporate Officer/Principal at Walden Biosciences, Inc.
Peter G. Linde active positions
| Companies | Position | Start | End |
|---|---|---|---|
Walden Biosciences, Inc.
 Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | 10/10/2022 | - |
Career history of Peter G. Linde
Former positions of Peter G. Linde
| Companies | Position | Start | End |
|---|---|---|---|
| MORPHIC HOLDING, INC. | Chief Tech/Sci/R&D Officer | 16/03/2020 | 30/12/2021 |
| FIBROGEN, INC. | Corporate Officer/Principal | - | - |
| ACCELERON PHARMA INC. | Corporate Officer/Principal | - | - |
Training of Peter G. Linde
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Finance | 2 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Walden Biosciences, Inc.
Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | Health Services |
- Stock Market
- Insiders
- Peter G. Linde
- Experience
